CD120

Error creating thumbnail:

CD120 refers to a receptor found on the surface of certain cells that is involved in the immune system's response to inflammation and infection. It is known to exist in two main forms: CD120a and CD120b, which are also recognized as the Tumor Necrosis Factor Receptor 1 (TNFR1) and 2 (TNFR2), respectively. These receptors are part of the TNF receptor superfamily, which plays a critical role in the regulation of immune response, cell proliferation, apoptosis (programmed cell death), and inflammation.

Function

CD120a and CD120b serve as receptors for Tumor Necrosis Factor (TNF) alpha, a potent cytokine involved in systemic inflammation and is one of the cytokines that make up the acute phase reaction. TNF-alpha is capable of inducing fever, apoptotic cell death, cachexia (wasting syndrome), inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNF production has been implicated in a variety of human diseases including Alzheimer's disease, cancer, major depression, and Inflammatory Bowel Disease (IBD).

Structure

CD120a (TNFR1) and CD120b (TNFR2) differ in their structure and function. TNFR1 is ubiquitously expressed in most tissue types and is capable of activating several signaling pathways leading to apoptosis or survival, depending on the cellular context. TNFR2 is primarily found on immune cells and certain endothelial cells and is thought to primarily promote survival and proliferation signals.

Signaling Pathways

Upon binding with TNF-alpha, CD120 receptors initiate a cascade of cellular signals that can lead to diverse cellular outcomes. The binding of TNF-alpha to TNFR1 can activate pathways leading to apoptosis through the recruitment of death domain-containing adaptor proteins. Alternatively, it can lead to the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and mitogen-activated protein kinases (MAPKs), promoting cell survival and inflammation. TNFR2 signaling is less well understood but is thought to primarily engage in promoting cell survival and proliferation, particularly in immune cells.

Clinical Significance

Given their central role in inflammation and cell death, CD120 receptors are targets for therapeutic intervention in various diseases. Drugs that inhibit TNF-alpha, such as infliximab and etanercept, are used to treat autoimmune diseases like rheumatoid arthritis, psoriasis, and IBD by blocking the interaction between TNF-alpha and its receptors, CD120a and CD120b.

Research Directions

Research continues to explore the complex roles of CD120a and CD120b in health and disease. Understanding the precise mechanisms by which these receptors signal in different cellular contexts is crucial for developing more targeted therapies for inflammatory and autoimmune diseases, as well as for cancer and neurodegenerative disorders.